NKX2-1 and lung adenocarcinoma: Furthermore, approximately 70% of lung adenocarcinomas (LADs) express TTF‐1 independent of disease stage and retain features of the TRU to a certain extent [6], strongly suggesting that NKX2‐1/TTF‐1 is a potential lineage survival oncogene in lung cancer [7].